Positron Emission Tomography (PET)-Computed Tomography (CT) in Inflammatory Bowel Disease (IBD)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00205062|
Recruitment Status : Terminated (No Accrual)
First Posted : September 20, 2005
Last Update Posted : October 5, 2015
|Condition or disease||Intervention/treatment||Phase|
|Inflammatory Bowel Diseases||Procedure: PET-CT||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Pilot Study of the Role of PET-CT for Diagnosis and Assessment of Therapeutic Efficacy in Inflammatory Bowel Disease|
|Study Start Date :||October 2004|
|Actual Primary Completion Date :||August 2008|
|Actual Study Completion Date :||August 2008|
- Does this technique provide an accurate assessment of disease inflammation compared to standard clinical markers?
- Does this technique provide additional information for practitioners on extent of disease?
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00205062
|United States, Wisconsin|
|University of Wisconsin|
|Madison, Wisconsin, United States, 53792|
|Principal Investigator:||Randall Meisner, MD||University of Wisconsin, Madison|